GB201503387D0 - Anti-carbapenem antibodies and uses thereof - Google Patents

Anti-carbapenem antibodies and uses thereof

Info

Publication number
GB201503387D0
GB201503387D0 GB201503387A GB201503387A GB201503387D0 GB 201503387 D0 GB201503387 D0 GB 201503387D0 GB 201503387 A GB201503387 A GB 201503387A GB 201503387 A GB201503387 A GB 201503387A GB 201503387 D0 GB201503387 D0 GB 201503387D0
Authority
GB
United Kingdom
Prior art keywords
carbapenem
antibodies
carbapenem antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB201503387A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Rapid Diagnostics Jena GmbH
Original Assignee
Alere Technologies GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alere Technologies GmbH filed Critical Alere Technologies GmbH
Priority to GB201503387A priority Critical patent/GB201503387D0/en
Publication of GB201503387D0 publication Critical patent/GB201503387D0/en
Priority to EP15808247.9A priority patent/EP3230741A1/en
Priority to PCT/EP2015/079487 priority patent/WO2016092096A1/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/978—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • G01N2333/986—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in cyclic amides (3.5.2), e.g. beta-lactamase (penicillinase, 3.5.2.6), creatinine amidohydrolase (creatininase, EC 3.5.2.10), N-methylhydantoinase (3.5.2.6)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
GB201503387A 2014-12-11 2015-02-27 Anti-carbapenem antibodies and uses thereof Ceased GB201503387D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB201503387A GB201503387D0 (en) 2015-02-27 2015-02-27 Anti-carbapenem antibodies and uses thereof
EP15808247.9A EP3230741A1 (en) 2014-12-11 2015-12-11 Anti-carbapenemase antibodies and uses thereof
PCT/EP2015/079487 WO2016092096A1 (en) 2014-12-11 2015-12-11 Anti-carbapenemase antibodies and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB201503387A GB201503387D0 (en) 2015-02-27 2015-02-27 Anti-carbapenem antibodies and uses thereof

Publications (1)

Publication Number Publication Date
GB201503387D0 true GB201503387D0 (en) 2015-04-15

Family

ID=52876274

Family Applications (1)

Application Number Title Priority Date Filing Date
GB201503387A Ceased GB201503387D0 (en) 2014-12-11 2015-02-27 Anti-carbapenem antibodies and uses thereof

Country Status (3)

Country Link
EP (1) EP3230741A1 (en)
GB (1) GB201503387D0 (en)
WO (1) WO2016092096A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7437000B2 (en) * 2016-07-01 2024-02-22 パラクライン セラピューティクス アーベー Methods and compositions for inhibition of PDGF-CC
US11591390B2 (en) 2018-09-27 2023-02-28 Celgene Corporation SIRP-α binding proteins and methods of use thereof
BR112021005585A2 (en) * 2018-09-27 2021-06-29 Celgene Corporation Sirpa binding proteins and methods of using them
CN113150138B (en) * 2021-02-01 2022-07-29 深圳市龙华区疾病预防控制中心 KPC-2 monoclonal antibody, and preparation method and application thereof
CN112501131B (en) * 2021-02-07 2021-05-04 天津一瑞生物科技股份有限公司 anti-IMP (anti-IMP) carbapenemase hybridoma cell strain, monoclonal antibody and application
CN112980803B (en) * 2021-05-12 2021-07-30 天津一瑞生物科技股份有限公司 VIM-resistant carbapenemase hybridoma cell strain, monoclonal antibody and application
CN112980804B (en) * 2021-05-12 2021-09-10 天津一瑞生物科技股份有限公司 KPC (Klebsiella pneumoniae Carbapenemase) resistant hybridoma cell strain, monoclonal antibody and application
CN114149988B (en) * 2022-02-10 2022-05-06 丹娜(天津)生物科技股份有限公司 Carbapenemase conserved antigen, antibody and application thereof
CN114317454B (en) * 2022-03-01 2023-10-03 天津一瑞生物科技股份有限公司 Mouse anti-OXA-48 type carbapenemase hybridoma cell strain, monoclonal antibody and application
CN114316056A (en) * 2022-03-02 2022-04-12 天津一瑞生物科技股份有限公司 Mouse NDM (Newcastle disease virus) -resistant carbapenemase hybridoma cell strain, monoclonal antibody and application
CN114755420B (en) * 2022-05-30 2023-02-03 广东聚诚生物技术有限公司 Carbapenemase combined detection kit

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20095544A0 (en) * 2009-05-15 2009-05-15 Juha Kirveskari Method and kit for identifying antibiotic resistant bacteria
EP2486131A1 (en) * 2009-10-06 2012-08-15 INSERM (Institut National de la Santé et de la Recherche Médicale) Carbapenemase and antibacterial treatment
ES2686336T3 (en) * 2011-04-21 2018-10-17 Biomerieux, Inc Method of detecting at least one mechanism of resistance to carbapenems by mass spectrometry
WO2013011072A1 (en) * 2011-07-20 2013-01-24 INSERM (Institut National de la Santé et de la Recherche Médicale) Carbapenemase and antibacterial treatment
WO2013112696A1 (en) * 2012-01-27 2013-08-01 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Compositions and methods for immunization against bacteria expressing a carbapenemase
AU2014248759B2 (en) * 2013-03-13 2020-02-27 Meso Scale Technologies, Llc. Improved assay methods

Also Published As

Publication number Publication date
WO2016092096A1 (en) 2016-06-16
EP3230741A1 (en) 2017-10-18

Similar Documents

Publication Publication Date Title
IL283321A (en) Anti-muc16 antibodies and uses thereof
IL285375A (en) Il-8-binding antibodies and uses thereof
HK1254861A1 (en) Anti-lag3 antibodies and uses thereof
HK1250238A1 (en) Anti-angptl8 antibodies and uses thereof
HK1255067A1 (en) Anti-c10orf54 antibodies and uses thereof
HK1243440A1 (en) Anti-interleukin-33 antibodies and uses thereof
IL247407B (en) Anti-egfrviii antibodies and uses thereof
HK1256381A1 (en) Anti-pacap antibodies and uses thereof
GB201503387D0 (en) Anti-carbapenem antibodies and uses thereof
IL251001A0 (en) Anti-il-25 antibodies and uses thereof
RS62912B1 (en) Anti-human-her3 antibodies and uses thereof
HK1254240A1 (en) Anti-hypusine antibodies and uses thereof

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)